摘要
人的大脑是人体内最多含胆固醇的器官,含有25%的总胆固醇。胆固醇存在于中枢神经系统(CNS),几乎完全从内源性合成,被循环的胆固醇无法穿越血脑屏障(BBB)。在这个过程中,星形胶质细胞似乎比神经元更活跃。神经元主要取决于胆固醇从附近的细胞的轴突再生,神经突起生长和突触形成的运输。在大脑中,胆固醇是由拟高密度脂蛋白的脂蛋白通过相关中枢神经系统中主要代表载脂蛋白转运。 虽然中枢神经系统的胆固醇含量主要是独立的膳食摄入量或肝合成,血浆胆固醇水平和神经退行性疾病具有联系,如经常被报道的阿尔茨海默氏病(AD)。在胆固醇代谢的改变这方面,显示在脑内的阿尔茨海默病和淀粉样蛋白生产的病因有牵连。因此,一个特别的关注应该是致力于控制大脑胆固醇代谢的主要因素的研究。 脑胆固醇水平受到严格控制:其过多的量可通过转换为可以达到血液24-s-羟基胆固醇(24-OH-C)氧化形式来降低。事实上,血脑屏障可渗透24-OH-C 以及 27-OH-C,是另一种氧化型胆固醇非神经细胞主要合成形式。 在这篇综述中,我们总结了调节胆固醇平衡的主要机制,并回顾了近来胆固醇和胆固醇氧化的产品在阿尔茨海默病中的作用的进展。此外,我们描述了可能的药理学策略,通过影响胆固醇平衡控制阿尔茨海默病进展。
关键词: 阿尔茨海默病,脑,血脑屏障,胆固醇代谢,氧化型胆固醇的他汀类药物,抗氧化剂。
Current Alzheimer Research
Title:The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease
Volume: 13 Issue: 2
Author(s): Anna Maria Giudetti, Adele Romano, Angelo Michele Lavecchia and Silvana Gaetani
Affiliation:
关键词: 阿尔茨海默病,脑,血脑屏障,胆固醇代谢,氧化型胆固醇的他汀类药物,抗氧化剂。
摘要: The human brain is the most cholesterol-rich organ harboring 25% of the total cholesterol pool of the whole body. Cholesterol present in the central nervous system (CNS) comes, almost entirely, from the endogenous synthesis, being circulating cholesterol unable to cross the blood-brain barrier (BBB). Astrocytes seem to be more active than neurons in this process. Neurons mostly depend on cholesterol delivery from nearby cells for axonal regeneration, neurite extension and synaptogenesis. Within the brain, cholesterol is transported by HDL-like lipoproteins associated to apoE which represents the main apolipoprotein in the CNS.
Although CNS cholesterol content is largely independent of dietary intake or hepatic synthesis, a relationship between plasma cholesterol level and neurodegenerative disorders, such as Alzheimer’s disease (AD), has often been reported. To this regard, alterations of cholesterol metabolism were suggested to be implicated in the etiology of AD and amyloid production in the brain. Therefore a special attention was dedicated to the study of the main factors controlling cholesterol metabolism in the brain.
Brain cholesterol levels are tightly controlled: its excessive amount can be reduced through the conversion into the oxidized form of 24-S-hydroxycholesetrol (24-OH-C), which can reach the blood stream. In fact, the BBB is permeable to 24-OH-C as well as to 27-OH-C, another oxidized form of cholesterol mainly synthesized by non- neural cells.
In this review, we summarize the main mechanisms regulating cholesterol homeostasis and review the recent advances on the role played by cholesterol and cholesterol oxidized products in AD. Moreover, we delineate possible pharmacological strategies to control AD progression by affecting cholesterol homeostasis.
Export Options
About this article
Cite this article as:
Anna Maria Giudetti, Adele Romano, Angelo Michele Lavecchia and Silvana Gaetani , The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease, Current Alzheimer Research 2016; 13 (2) . https://dx.doi.org/10.2174/1567205012666150921103426
DOI https://dx.doi.org/10.2174/1567205012666150921103426 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Substance Abuse and Movement Disorders
Current Drug Abuse Reviews Steroid Induced Bilateral Avascular Necrosis of Head of Femur in an Adult Male Patient - A Case Report
Current Drug Safety Neuropsychiatric Systemic Lupus Erythematosus
Current Neuropharmacology Therapeutic Neovascularization by the Implantation of Autologous Mononuclear Cells in Patients with Connective Tissue Diseases
Current Pharmaceutical Design Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Current Pharmaceutical Design Anti-Endothelial Cell Antibodies in Patients with Cerebral Small Vessel Disease
Current Neurovascular Research Regulatory Roles of the Ubiquitin-Proteasome System in Cardiomyocyte Apoptosis
Current Molecular Medicine Pharmacology of TRP Channels in the Vasculature
Current Vascular Pharmacology Cutaneous Lupus Erythematosus in Children
Current Pediatric Reviews Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Current Cardiology Reviews Dyslipidaemia Related to Insulin Resistance and Cardiovascular Disease in South Asian and West African Populations
Current Pharmaceutical Design The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases
Current Drug Metabolism HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Mouse Models of Autoimmune Uveitis
Current Pharmaceutical Design The Role of Infections in the Pathogenesis of Autoimmune Diseases
Current Drug Targets - Inflammation & Allergy Incretin Pharmacology: A Review of the Incretin Effect and Current Incretin-Based Therapies
Cardiovascular & Hematological Agents in Medicinal Chemistry Brain Delivery of Chemotherapeutics in Brain Cancer
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases
Current Drug Targets Functions of S100 Proteins
Current Molecular Medicine